CD44 expression and regulation during mammary gland development and function

QUICK SEARCH:

[advanced]

	Author:		Keyword(s):

Home Help Feedback Subscriptions Archive Search Table of Contents

This Article

	Summary
	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted

Services

	Email this article to a friend
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Download to citation manager


Citing Articles

	Citing Articles via HighWire
	Citing Articles via Google Scholar

Google Scholar

	Articles by Hebbard, L.
	Articles by Sleeman, J.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Hebbard, L.
	Articles by Sleeman, J.

Ball, R., Friis, R., Schoenenberger, C., Doppler, W. and Groner, B (1988). Prolactin regulation of-casein gene expression and of a cytosolic 120-kd protein in a cloned mouse mammary epithelial cell line. EMBO J 7, 2089-2095.[Medline]

Bell, M., Cowper, A., Lefranc, M., Bell, J. and Screaton, G (1998). Influence of intron length on alternative splicing of CD44. Mol. Cell Biol 18, 5930-5941.[Abstract/Free Full Text]

Bennett, K., Jackson, D., Simon, J., Tanczos, E., Peach, R., Modrell, B., Stamenkovic, I., Plowman, G. and Aruffo, A (1995). CD44 isoforms containing exon v3 are responsible for the presentation of heparin-binding growth factor. J. Cell Biol 128, 687-698.[Abstract/Free Full Text]

Berger, M., Locher, G., Saurer, S., Gullick, W., Waterfield, M., Groner, B. and Hynes, N (1988). Correlation of c-erbB-2 gene amplification and protein expression in humanbreast carcinoma with nodal status and nuclear grading. Cancer Res 48, 1238-1243.[Abstract/Free Full Text]

Chammas, R., Taverna, D., Cella, N., Santos, C. and Hynes, N (1994). Laminin and tenascin assembly and expression regulate HC11 mouse mammary cell differentiation. J. Cell Sci 107, 1031-1040.[Abstract]

Coleman, S. and Daniel, C (1990). Inhibition of mouse ductal morphogenesis and down-regulation of the EGF receptor by epidermal growth factor. Dev. Biol 137, 425-433.[Medline]

Dall, P., Heider, K.-H., Sinn, H.-P., Skroch-Angel, P., Adolf, G., Kaufmann,M., Herrlich, P. and Ponta, H (1995). Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer,. Int. J. Cancer 60, 471-477.[Medline]

Deugnier, M.-A., Faraldo, M., Rousselle, P., Thiery, J.-P. and Glukhova, M (1999). Cell-extracellular matrix interactions and EGF are important regulators of the basal mammary epithelial cell phenotype. J. Cell Sci 112, 1035-1044.[Abstract]

Dulbecco, R., Allen, W. R., Bologna, M. and Bowman, M (1986). Marker evolution during the development of the rat mammary gland: stem cells identified by markers and the role of myoepithelial cells. Cancer Res 46, 2449-2456.[Abstract/Free Full Text]

Earp, H., Dawson, T., Li, X. and Yu, H (1995). Heterodimersization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research. Breast Cancer Res. Treat 35, 115-132.[Medline]

Foekens, J., Dall, P., Klijn, J., Skorch-Angel, P., Claasen, C., Look, M., Ponta, P., van Putten, W., Herrlich, P. and Henzen-Logmans, S (1999). Prognostic value of CD44 variant expression in primary breast cancer. Int. J. Cancer, 84, 209-215.[Medline]

Fox, S., Smith, K., Hollyer, J., Greenall, M., Hastrich, D. and Harris, A (1994). The epidermal growth factor receptor as a prognostic marker: results of 370 patients and review of 3009 patients. Breast Cancer Res. Treat 29, 41-49.[Medline]

Friedrichs, K., Franke, F., Lisboa, B.-W., Kugler, G., Gille, I., Terpe, H.-J., H\232lzel, F., Maass, H. and Gunthert, U (1995). CD44 isoforms correlate with cellular differentiation but not with prognosis is human breast cancer. Cancer Res 55, 5424-5433.[Abstract/Free Full Text]

Hofmann, M., Rudy, W., Gunthert, U., Zimmer, S., Zawadzki, V., Z\232ller, M., Lichtner, R., Herrlich, P. and Ponta, H (1993). A link between ras and metastatic behaviour of tumor cells: ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells. Cancer Res 53, 1516-1521.[Abstract/Free Full Text]

Hofmann, M., Fieber, C., Assmann, V., G\232ttlicher, M., Sleeman, J. P., Plug, R., Howells, N., von Stein, O., Ponta, H. and Herrlich, P (1998). Identification of IHABP, a 95 kDa intracellular hyaluronate binding protein. J. Cell Sci 111, 1673-1684.[Abstract]

Humphreys, R. and Rosen, J (1997). Stably transfected HC11 cells provide an in vitro and in vivo model system for studying Wnt gene function. Cell Growth Differ 8, 839-849.[Abstract]

Jansen, R., Joosten-Achjanie, S., Arends, J., Volovics, A., Hupperets, P., Schouten, H. and Hillen, H (1998). CD44v6 is not a prognostic factor in primary breast cancer. Ann. Oncol 9, 109-111.[Abstract/Free Full Text]

Katagiri, Y., Sleeman, J., Fujii, H., Herrlich, P., Hotta, H., Tanaka, K., Chikuma, S., Yagita, H., Okumura, K., Murakami, M., Saiki, I., Chambers, A. and Uede, T (1999). CD44 variants but not CD44s cooperate with1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis. Cancer Res 59, 219-226.[Abstract/Free Full Text]

Kaufmann, M., Heider, K.-H., Sinn, H.-P., von Minckwitz, G., Ponta, H. and Herrlich, P (1995). CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet 345, 615-619.[Medline]

Kleinberg, D (1998). Role of IGF-1 in normal mammary development. Breast Cancer Res. Treat 47, 201-208.[Medline]

K\232nig, H., Moll, J., Ponta, H. and Herrlich, P (1996). Trans-acting factors regulate the expression of CD44 splice variants. EMBO J 15, 4030-4039.[Medline]

K\232nig, H., Ponta, H. and Herrlich, P (1998). Coupling of signal transduction to alternative pre-mRNA splicing by a composite splice regulator. EMBO J 17, 2904-2913.[Medline]

Klijn, J., Berns, P., Schmitz, P. and Foekens, J (1992). The clinical significance of epidermal growth factor recptor (EGF-R) in human breast cancer: a review on 5232 patients. Endocr. Rev 13, 3-17.[Abstract]

Naor, D., Sionov, R. and Ish-Shalom, D (1997). CD44: Structure, function and association with the malignant process. Advan. Cancer Res 71, 241-319.[Medline]

Nordeen, S (1988). Luciferase reporter gene vectors for analysis of promoters and enhancers. BioTechniques 6, 454-457.[Medline]

Nottenburg, C., Rees, G. and St John, T (1989). Isolation of mouse CD44 cDNA: Structural features are distinct from the primate cDNA. Proc. Nat. Acad. Sci. USA 86, 8521-8525.[Abstract/Free Full Text]

Omerod, E. J. and Rudland, P (1986). Regeration of mammary glands in vivo from isolated mammary ducts. J. Embryol. Exp. Morphol 96, 229-243.[Medline]

Peyrat, J. and Bonneterre, J (1992). Type 1 IGF receptor in human breast diseases. Breast Cancer Res. Treat 22, 59-67.[Medline]

Peyrat, J., Bonneterre, J., Hecquet, B., Vennin, P., Louchez, M., Fournier, C., Lefebvre, J. and Demaille, A (1993). Plasma insulin-like growth factor 1 (IGF-1) concentrations in human breast cancer. Eur. J. Cancer 29, 492-497.

Radnor, C (1972). Myoepithelial cell differentiation in rat mammary glands. J. Anat 111, 381-398.[Medline]

Reber, S., Matzku, S., Gunthert, U., Ponta, H., Herrlich, P. and Z\232ller, M (1990). Retardation of metastatic tumor growth after immunization with metastasis-specific monoclonal antibodies. Int. J. Cancer 46, 919-927.[Medline]

Ruan, W., Catanese, V., Wieczorek, Feldman, M. and Kleinberg, D (1995). Estradiol enhances the stimulatory effect of insulin-like growth factor-1 (IGF-1) on mammary development and growth hormone-induced IGF-1 messenger ribonucleic acid. Endocrinology 136, 1296-1302.[Abstract]

Rudland, P (1987). Stem cells and the development of mammary cancers in experimental rats and in humans. Cancer Metast. Rev 6, 55-83.[Medline]

Rudy, W., Hofmann, M., Schwartz-Albiez, R., Z\232ller, M., Heider, K.-H., Ponta, H. and Herrlich, P (1993). The two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: each one individually suffices to confer metastatic behavior. Cancer Res 53, 1262-1268.[Abstract/Free Full Text]

Sainsbury, J., Farndon, J., Needham, G., Malcom, A. and Harris, A (1987). Epidermal growth factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet 1, 1398-1402.[Medline]

Sch\232nenberger, C.-A., Zuk, A., Groner, B., Jones, W. and Andres, A.-C (1990). Induction of the endogenous whey acidic protein (wap) gene and a wap-myc hybrid gene in primary murine mammary organoids. Dev. Biol 139, 327-337.[Medline]

Seiter, S., Arch, R., Komitowski, D., Hofmann, M., Ponta, H., Herrlich, P., Matzku, S. and Z\232ller, M (1993). Prevention of tumor metastasis formation by anti-variant CD44. J. Exp. Med 177, 443-455.[Abstract/Free Full Text]

Sherman, L., Wainwright, D., Ponta, H. and Herrlich, P (1998). A splice variant of CD44 expressed in the apical ectodermal ridge presents fibroblast growth factors to limb mesenchyme and is required for limb outgrowth. Genes Dev 12, 1058-1071.[Abstract/Free Full Text]

Shtivelman, E. and Bishop, J. M (1991). Expression of CD44 is repressed in neuroblastoma cells. Mol. Cell Biol 11, 5446-5453.[Abstract/Free Full Text]

Sinn, H.-P., Heider, K.-H., Skroch-Angel, P., von Minckwitz, G., Kaufmann, M., Herrlich, P. and Ponta, P (1995). Human mammary carcinomas express homologues of rat metastasis-associated variants of CD44. Breast Cancer Res. Treat 36, 307-313.[Medline]

Sleeman, J. P., Arming, S., Moll, J., Hekele, A., Rudy, W., Sherman, L., Kreil, G., Ponta, H. and Herrlich, P (1996). Hyaluronate-independent metastatic behavior of CD44 variant-expressing pancreatic carcinoma cells. Cancer Res 56, 3134-3141.[Abstract/Free Full Text]

Sonnenberg, A., Daams, H., van der Valk, M., Hilkens, J. and Hilgers, J (1986). Development of the mouse mammary gland: identification of stages in differentiation of luminal and myoepithelial cells using monoclonalantibodies and polyvalent antiserum against keratin. J. Histochem. Cytochem 34, 1037-1046.[Abstract]

Tempfer, C., Losch, A., Heinzl, H., Hausler, G., Hanzal, E., Kolbl, H., Breitenecker, G. and Kainz, C (1996). Prognostic value of immunohistochemically detected CD44 isoforms CD44v5, CD44v6 and CD44v7-8 in human breast cancer. Eur. J. Cancer 32, 2023-2025.

Tokue, Y., Matsumura, Y., Katsumata, N., Watanabe, T., Tarin, D. and Kakizoe, T (1998). CD44 variant isoform expression and breast cancer prognosis. Jpn. J. Cancer Res 89, 283-290.[Medline]

T\232lg, C., Hofmann, M., Herrlich, P. and Ponta, H (1993). Splicing choice from ten variant exons establishes CD44 variability. Nucl. Acids Res 21, 1225-1229.[Abstract/Free Full Text]

Topper, Y. and Freeman, C (1980). Multiple hormone interactions in thedevelopmental biology of the mammary gland. Phys. Rev 60, 1049-1106.[Free Full Text]

Trowbridge, I., Lesley, J., Schulte, R., Hyman, R. and Trotter, J (1982). Biochemical characterisation and cellular distribution of a polymorphic murine cell-surface glycoprotein expressed in lymphoid tissues. Immunogenetics 15, 299-312.[Medline]

van Weering, D. H., Baas, P. D. and Bos, J. L (1993). A PCR-based method for the analysis of human CD44 splice products. PCR Meth. Appl 3, 100-1066.

Weiss, J. M., Sleeman, J. P., Renkl, A. C., Termeer, C., Dittmar, H., Taxis, S., Howells, N., Hofmann, M., Sch\232pf, E., Ponta, H., Herrlich P. and Simon, J. C (1997). An essential role for CD44 variant isoforms in epidermal Langerhans cell and blood dendritic cell function. J. Cell Biol 137, 1-11.[Free Full Text]

Wellings, S. and Jensen, H (1973). On the origin and progression of ductal carcinoma in the human breast. J. Nat. Cancer Inst 50, 1111-1118.

Williams, J. and Daniels, C (1983). Mammary ductal elongation: differentiation of myoepithelium and basal lamina during branching morphogenesis. Dev. Biol 97, 274-290.[Medline]

Winstanley, J., Cooke, T., Murray, G., Platt-Higgins. A., George, W., Holt, S., Myskov, M., Spedding, A., Barraclough, B. and Rudland, P (1991). The long term prognostic significance of c-erbB-2 in primary breast cancer. Br. J. Cancer 63, 447-450.[Medline]

Xie, W, Paterson, A., Chin, E., Nabell, L. and Kudlow, J (1997). Targeted expression of a dominant negative epidermal growth factor receptor in the mammary gland of transgenic mice inhibits pubertal mammary duct development. Mol. Endocrinol 11, 1766-1781.[Abstract/Free Full Text]

Yu, Q. and Stamenkovic, I (1999). Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev 13, 35-48.[Abstract/Free Full Text]

This article has been cited by other articles:

G. Pacheco-Rodriguez, W. K. Steagall, D. M. Crooks, L. A. Stevens, H. Hashimoto, S. Li, J.-a. Wang, T. N. Darling, and J. Moss
TSC2 Loss in Lymphangioleiomyomatosis Cells Correlated with Expression of CD44v6, a Molecular Determinant of Metastasis
Cancer Res., November 1, 2007; 67(21): 10573 - 10581.
[Abstract] [Full Text] [PDF]

K. P. Greenberg, S. F. Geller, D. V. Schaffer, and J. G. Flannery
Targeted Transgene Expression in Muller Glia of Normal and Diseased Retinas Using Lentiviral Vectors
Invest. Ophthalmol. Vis. Sci., April 1, 2007; 48(4): 1844 - 1852.
[Abstract] [Full Text] [PDF]

M. Balic, H. Lin, L. Young, D. Hawes, A. Giuliano, G. McNamara, R. H. Datar, and R. J. Cote
Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype.
Clin. Cancer Res., October 1, 2006; 12(19): 5615 - 5621.
[Abstract] [Full Text] [PDF]

L. K. Diaz, X. Zhou, E. T. Wright, M. Cristofanilli, T. Smith, Y. Yang, N. Sneige, A. Sahin, and M. Z. Gilcrease
CD44 Expression Is Associated with Increased Survival in Node-Negative Invasive Breast Carcinoma
Clin. Cancer Res., May 1, 2005; 11(9): 3309 - 3314.
[Abstract] [Full Text] [PDF]

J. A. Recio and G. Merlino
Hepatocyte Growth Factor/Scatter Factor Induces Feedback Up-Regulation of CD44v6 in Melanoma Cells through Egr-1
Cancer Res., April 1, 2003; 63(7): 1576 - 1582.
[Abstract] [Full Text] [PDF]

J. Mengwasser, F.-T. Liu, and J. P. Sleeman
Galectin-3 is strongly up-regulated in nonapoptosing mammary epithelial cells during rat mammary gland involution
Glycobiology, February 1, 2002; 12(2): 129 - 134.
[Abstract] [Full Text] [PDF]

This Article

Summary

Full Text (PDF)

Alert me when this article is cited

Alert me if a correction is posted

Services

Email this article to a friend

Similar articles in this journal

Similar articles in PubMed

Alert me to new issues of the journal

Download to citation manager

Citing Articles

Citing Articles via HighWire

Citing Articles via Google Scholar

Google Scholar

Articles by Hebbard, L.

Articles by Sleeman, J.

Search for Related Content

PubMed

PubMed Citation

Articles by Hebbard, L.

Articles by Sleeman, J.

				K. P. Greenberg, S. F. Geller, D. V. Schaffer, and J. G. Flannery Targeted Transgene Expression in Muller Glia of Normal and Diseased Retinas Using Lentiviral Vectors Invest. Ophthalmol. Vis. Sci., April 1, 2007; 48(4): 1844 - 1852. [Abstract] [Full Text] [PDF]

				M. Balic, H. Lin, L. Young, D. Hawes, A. Giuliano, G. McNamara, R. H. Datar, and R. J. Cote Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype. Clin. Cancer Res., October 1, 2006; 12(19): 5615 - 5621. [Abstract] [Full Text] [PDF]

				L. K. Diaz, X. Zhou, E. T. Wright, M. Cristofanilli, T. Smith, Y. Yang, N. Sneige, A. Sahin, and M. Z. Gilcrease CD44 Expression Is Associated with Increased Survival in Node-Negative Invasive Breast Carcinoma Clin. Cancer Res., May 1, 2005; 11(9): 3309 - 3314. [Abstract] [Full Text] [PDF]

				J. A. Recio and G. Merlino Hepatocyte Growth Factor/Scatter Factor Induces Feedback Up-Regulation of CD44v6 in Melanoma Cells through Egr-1 Cancer Res., April 1, 2003; 63(7): 1576 - 1582. [Abstract] [Full Text] [PDF]

				J. Mengwasser, F.-T. Liu, and J. P. Sleeman Galectin-3 is strongly up-regulated in nonapoptosing mammary epithelial cells during rat mammary gland involution Glycobiology, February 1, 2002; 12(2): 129 - 134. [Abstract] [Full Text] [PDF]